PBM Act

Bill 118 s 1967, also known as the PBM Act, is a piece of legislation currently being considered by the US Congress. The bill aims to regulate pharmacy benefit managers (PBMs), which are companies that manage prescription drug benefits on behalf of health insurers and employers.

The PBM Act seeks to increase transparency and accountability in the PBM industry by requiring PBMs to disclose information about their pricing practices, rebates, and discounts. This information would be made available to the public and to the government, allowing for greater oversight of the industry.

Additionally, the bill includes provisions to address conflicts of interest within the PBM industry. It prohibits PBMs from engaging in certain practices, such as steering patients towards certain drugs based on financial incentives, and requires them to act in the best interests of their clients. Overall, the PBM Act aims to protect consumers and ensure that PBMs are operating in a fair and ethical manner. Supporters of the bill argue that it will help lower prescription drug costs and improve access to medications for all Americans. Critics, however, raise concerns about the potential impact of increased regulation on the PBM industry and on the overall healthcare system. As the bill makes its way through Congress, lawmakers will continue to debate its merits and potential consequences. It remains to be seen whether the PBM Act will ultimately be passed into law and what impact it will have on the healthcare industry as a whole.